Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression:: Involvement of p38 mitogen-activated protein kinase

被引:99
|
作者
Weng, MS
Ho, YS
Lin, JK
机构
[1] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei 10018, Taiwan
[2] Taipei Med Univ, Grad Inst Biomed Technol, Taipei, Taiwan
关键词
chrysin; cell cycle; p21(Waf1/Cip1); p38-MAPK; proteasome activity;
D O I
10.1016/j.bcp.2005.03.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Flavonoids are a broadly distributed class of plant pigments, universally present in plants. They are strong anti-oxidants that can inhibit carcinogenesis in rodents. Chrysin (5,7-dihydroxyflavone) is a natural and biologically active compound extracted from many plants, honey, and propolis. It possesses potent anti-inflammatory, anti-oxidant properties, promotes cell death, and perturbing cell cycle progression. However, the mechanism by which chrysin inhibits cancer cell growth remains poorly understood. Therefore, we developed an interest in the relationship between MAPK signaling pathways and cell growth inhibition after chrysin treatment in rat C6 glioma cells. Cell viability assay and flow cytometric analysis suggested that chrysin exhibited a dose-dependent and time-dependent ability to block rat C6 glioma cell line cell cycle progression at the G1 phase. Western blotting analysis showed that the levels of Rb phosphorylation in C6 glioma cells exposed to 30 mu M chrysin for 24 It decreased significantly. We demonstrated the expression of cyclin-dependent kinase inhibitor, p21(Waf1/Cip1), to be significantly increased, but the p53 protein level did not change in chrysin-treated cells. Both cyclin-dependent kinase 2 (CDK2) and 4 (CDK4) kinase activities were reduced by chrysin in a dose-dependent manner. Furthermore, chrysin also inhibited proteasome activity. We further showed that chrysin induced p38-MAPK activation, and using a specific p38-MAPK inhibitor, SB203580, attenuated chrysin-induced p21(waf1/Cio1) expression. These results suggest that chrysin exerts its growth-inhibitory effects either through activating p38-MAPK leading to the accumulation of p21(Waf1/Cip1) protein or mediating the inhibition of proteasome, activity. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1815 / 1827
页数:13
相关论文
共 50 条
  • [41] ABROGATION OF P53-INDUCED CELL-CYCLE ARREST BY C-MYC - EVIDENCE FOR AN INHIBITOR OF P21(WAF1/CIP1/SDI1)
    HERMEKING, H
    FUNK, JO
    REICHERT, M
    ELLWART, JW
    EICK, D
    ONCOGENE, 1995, 11 (07) : 1409 - 1415
  • [42] Activation of protein kinase Cα inhibits growth of pancreatic cancer cells via p21cip-mediated G1 arrest
    Detjen, KM
    Brembeck, FH
    Welzel, M
    Kaiser, A
    Haller, H
    Wiedenmann, B
    Rosewicz, S
    JOURNAL OF CELL SCIENCE, 2000, 113 (17) : 3025 - 3035
  • [43] Iron suppresses ovarian granulosa cell proliferation and arrests cell cycle through regulating p38 mitogen-activated protein kinase/p53/p21 pathway
    Chen, Mei-Jou
    Chou, Chia-Hong
    Shun, Chia-Tung
    Mao, Tsui-Lien
    Wen, Wen-Fen
    Chen, Chin-Der
    Chen, Shee-Uan
    Yang, Yu-Shih
    Ho, Hong-Nerng
    BIOLOGY OF REPRODUCTION, 2017, 97 (03) : 438 - 448
  • [44] Curcurnin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBPβ expressions and suppressing NF-κB activation
    Hour, TC
    Chen, J
    Huang, CY
    Guan, JY
    Lu, SH
    Pu, YS
    PROSTATE, 2002, 51 (03) : 211 - 218
  • [45] Endothelin-1 activates p38 mitogen-activated protein kinase via endothelin-A receptor in rat myocardial cells
    Tomomi Ueyama
    Seinosuke Kawashima
    Tsuyoshi Sakoda
    Yoshiyuki Rikitake
    Tatsuro Ishida
    Miki Kawai
    Masayuki Namiki
    Mitsuhiro Yokoyama
    Molecular and Cellular Biochemistry, 1999, 199 : 119 - 124
  • [46] A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer
    Johanna C. Bendell
    Helge G. Bischoff
    Jimmy Hwang
    Hans Christian Reinhardt
    Thomas Zander
    Xuejing Wang
    Scott Hynes
    Celine Pitou
    Robert Campbell
    Philip Iversen
    Daphne L. Farrington
    Katherine Bell-McGuinn
    Michael Thomas
    Investigational New Drugs, 2020, 38 : 1145 - 1155
  • [47] A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer
    Bendell, Johanna C.
    Bischoff, Helge G.
    Hwang, Jimmy
    Reinhardt, Hans Christian
    Zander, Thomas
    Wang, Xuejing
    Hynes, Scott
    Pitou, Celine
    Campbell, Robert
    Iversen, Philip
    Farrington, Daphne L.
    Bell-McGuinn, Katherine
    Thomas, Michael
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (04) : 1145 - 1155
  • [48] Involvement of p38 Mitogen-Activated Protein Kinase and Apoptosis Signal-Regulating Kinase-1 in Nitric Oxide-Induced Cell Death in PC12 Cells
    Ok-Jin Han
    Keun Ho Joe
    Seong Won Kim
    Hee Sung Lee
    Nyoun Soo Kwon
    Kwang Jin Baek
    Hye-Young Yun
    Neurochemical Research, 2001, 26 : 525 - 532
  • [49] RXR antagonism induces G0/G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21Cip1 pathway in adipocytes
    Nakatsuka, Atsuko
    Wada, Jun
    Hida, Kazuyuki
    Hida, Aya
    Eguchi, Jun
    Teshigawara, Sanae
    Murakami, Kazutoshi
    Kanzaki, Motoko
    Inoue, Kentaro
    Terami, Takahiro
    Katayama, Akihiro
    Ogawa, Daisuke
    Kagechika, Hiroyuki
    Makino, Hirofumi
    JOURNAL OF PATHOLOGY, 2012, 226 (05) : 784 - 795
  • [50] Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest
    Yang, Hua
    Xu, Wenfang
    Li, Yan
    Lan, Peixiang
    Zhang, Jian
    Zhang, Yingjie
    Zhang, Cai
    ANTI-CANCER DRUGS, 2014, 25 (07) : 767 - 777